Conatus Pharmaceuticals Inc. Uncategorized Contracts & Agreements
17 Contracts & Agreements
- Plan of Dissolution of Histogen Inc (Filed With SEC on September 18, 2023)
- Engagement Letter, dated March 1, 2022, between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on March 25, 2022)
- Description of Securities (Filed With SEC on March 10, 2022)
- Executive Agreement, dated November 5, 2021, by and between the Company and Steven J. Mento, Ph.D (Filed With SEC on November 8, 2021)
- Amendment to Engagement Letter between Histogen Inc. and H.C. Wainwright & Co., LLC, dated as of June 6, 2021 (Filed With SEC on June 8, 2021)
- Engagement Letter between Histogen Inc. and H.C. Wainwright & Co., LLC, dated as of December 28, 2020 (Filed With SEC on December 29, 2020)
- Engagement Letter between Histogen Inc. and H.C. Wainwright & Co., LLC, dated as of November 10, 2020 (Filed With SEC on November 12, 2020)
- Letter Agreement, dated November 8, 2019, by and between Histogen Inc. and Canaccord Genuity LLC (Filed With SEC on February 7, 2020)
- Second Amended and Restated Strategic Relationship Success Fee Agreement, dated January 28, 2020, by and between Histogen Inc. and Lordship Ventures LLC (Filed With SEC on February 7, 2020)
- Support Agreement, dated January 28, 2020, by and among Conatus Pharmaceuticals Inc., Histogen Inc. and certain stockholders of Histogen Inc (Filed With SEC on January 28, 2020)
- Support Agreement, dated January 28, 2020 by and among Conatus Pharmaceuticals Inc., Histogen Inc. and certain stockholders of Conatus Pharmaceuticals Inc (Filed With SEC on January 28, 2020)
- FOURTH AMENDMENT (Filed With SEC on July 8, 2013)
- Additional abbreviations may also be used though not in the above list. (Filed With SEC on July 8, 2013)
- SUBLICENSE AGREEMENT (Filed With SEC on June 14, 2013)
- 4365 Executive Drive, Suite 100, San Diego, CA 92121 ###-###-#### (Filed With SEC on June 14, 2013)
- 4365 Executive Drive, Suite 100, San Diego, CA 92121 ###-###-#### SECOND AMENDMENT (Filed With SEC on June 14, 2013)
- FIRST AMENDMENT (Filed With SEC on June 14, 2013)
